Terms: = Brain cancer AND FANCD2, FANCD, 2177, ENSG00000144554, FLJ23826, FAD, FACD, FA4, FA-D2, FAD2, DKFZp762A223 AND Prognosis
4 results:
1. fancd2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis.
Zhou H; Wang YX; Wu M; Lan X; Xiang D; Cai R; Ma Q; Miao J; Fang X; Wang J; Luo D; He Z; Cui Y; Liang P; Wang Y; Bian XW
J Pathol; 2024 Apr; 262(4):427-440. PubMed ID: 38229567
[TBL] [Abstract] [Full Text] [Related]
2. Downregulated ferroptosis-related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma.
Yao L; Li J; Zhang X; Zhou L; Hu K
CNS Neurosci Ther; 2022 Dec; 28(12):2104-2115. PubMed ID: 35962621
[TBL] [Abstract] [Full Text] [Related]
3. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and prognosis.
Liu Y; Xu Z; Jin T; Xu K; Liu M; Xu H
Med Sci Monit; 2020 Jun; 26():e921947. PubMed ID: 32484805
[TBL] [Abstract] [Full Text] [Related]
4. Celastrol-induced degradation of fancd2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin.
Metselaar DS; Meel MH; Benedict B; Waranecki P; Koster J; Kaspers GJL; Hulleman E
EBioMedicine; 2019 Dec; 50():81-92. PubMed ID: 31735550
[TBL] [Abstract] [Full Text] [Related]